Equatorial Guinea vs Uruguay: The number of people with susceptibility test result for rifampicin
Equatorial Guinea
492
in 2021
Uruguay
510
in 2021
Equatorial Guinea rank
80th
Uruguay rank
78th
The number of people with susceptibility test result for rifampicin over time
- Equatorial Guinea
- Uruguay
How they compare
Uruguay currently reports 510 against 492 in Equatorial Guinea, a difference of 18.
Across all 5 years both countries report, Uruguay has been ahead every year.
Equatorial Guinea ranks 80th and Uruguay ranks 78th of 155 countries.
Uruguay has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Equatorial Guinea | Uruguay | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 31.33 | 508 | 476.67 | Uruguay |
| 2020s | 371 | 493 | 122 | Uruguay |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Equatorial Guinea or Uruguay?
- Uruguay, at 510 against 492 in Equatorial Guinea as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Equatorial Guinea and Uruguay?
- 18, with Uruguay ahead.
- How many years of comparable data are there for Equatorial Guinea and Uruguay?
- 5 years are reported by both, from 2017 to 2021.
- How do Equatorial Guinea and Uruguay rank globally for the number of people with susceptibility test result for rifampicin?
- Equatorial Guinea ranks 80th and Uruguay ranks 78th of 155 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid refreshes it automatically from the source and publishes the full history for both places.